Fig. 3From: Clinical impact of 99mTc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patientsClinical adverse events (AEs) at 4 weeksBack to article page